• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Identification of MMV Malaria Box inhibitors of Plasmodium falciparum Early-Stage Gametocytes, Using a Luciferase-Based High-Throughput Assay

    Thumbnail
    View/Open
    90026_1.pdf (4.516Mb)
    Author(s)
    Lucantoni, Leonardo
    Duffy, Sandra
    Adjalley, Sophie H
    Fidock, David A
    Avery, Vicky M
    Griffith University Author(s)
    Duffy, Sandra
    Avery, Vicky M.
    Year published
    2013
    Metadata
    Show full item record
    Abstract
    The design of new antimalarial combinations to treat Plasmodium falciparum infections requires drugs that, in addition to resolving disease symptoms caused by asexual blood stage parasites, can also interrupt transmission to the mosquito vector. Gametocytes, which are essential for transmission, develop as sexual blood stage parasites in the human host over 8-12 days and are the most accessible developmental stage for transmission-blocking drugs. Considerable effort is currently being devoted to identifying compounds active against mature gametocytes. However, investigations on the drug sensitivity of developing gametocytes, ...
    View more >
    The design of new antimalarial combinations to treat Plasmodium falciparum infections requires drugs that, in addition to resolving disease symptoms caused by asexual blood stage parasites, can also interrupt transmission to the mosquito vector. Gametocytes, which are essential for transmission, develop as sexual blood stage parasites in the human host over 8-12 days and are the most accessible developmental stage for transmission-blocking drugs. Considerable effort is currently being devoted to identifying compounds active against mature gametocytes. However, investigations on the drug sensitivity of developing gametocytes, as well as screening methods for identifying inhibitors of early gametocytogenesis, remain scarce. We have developed a luciferase-based high-throughput screening (HTS) assay using tightly synchronous stage I - III gametocytes from a recombinant P. falciparum line expressing GFP-luciferase. The assay has been used to evaluate the early stage gametocytocidal activity of the MMV Malaria Box, a collection of 400 compounds with known antimalarial (asexual blood stage) activity. Screening this collection against early-stage (I-III) gametocytes yielded 64 gametocytocidal compounds with IC50 values below 2.5 卮 This assay is reproducible and suitable for the screening of large compound libraries, with an average % coefficient of variance (CV) = 5%, an average signal to noise ratio (S:N) > 30 and a Z' ~0.8. Our findings highlight the need for screening efforts directed specifically against early gametocytogenesis, and indicate the importance of experimental verification of early stage gametocytocidal activity in the development of new antimalarial candidates for combination therapy.
    View less >
    Journal Title
    Antimicrobial agents and Chemotherapy
    Volume
    57
    Issue
    12
    DOI
    https://doi.org/10.1128/AAC.00870-13
    Copyright Statement
    © 2013 American Society for Microbiology. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
    Subject
    Microbiology
    Infectious agents
    Medical microbiology
    Pharmacology and pharmaceutical sciences
    Publication URI
    http://hdl.handle.net/10072/56386
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander